chevron_leftBack
As of 8 June 2026, Zhejiang Xinguang Pharmaceutical Co., Ltd. has a market cap of $382.66M USD, ranking #16988 globally and #5299 in China.
It ranks #1541 in the Healthcare sector, and #84 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$382.66MUSD
2.59B CNY
Enterprise Value
$268.5MUSD
1.82B CNY
Revenue (TTM)
$39.2MUSD
265.36M CNY
EBITDA (TTM)
$9.31MUSD
63.09M CNY
Net Income (TTM)
$8.01MUSD
54.21M CNY
EBITDA Margin
24%
Profit Margin
20%
PE Ratio
47.6
PS Ratio
9.8
PB Ratio
3.1
EV/EBITDA
28.8
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Yue Jun Wang
open_in_new
Employees
316
Founded
1998
Website
xgpharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0.7% | 2.3% | 4.9% | 2.1% | -0.1% | 21% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
300519
浙江新光药业股份有限公司 Class A
ISIN: CNE1000027T3
Shares Out.:
Shares Outstanding:
160.0M1
Shares Float:
74.627M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
16.31 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Xinguang Pharmaceutical Co., Ltd.
Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
4K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
2K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
1K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
999%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
754%
22.12B CNY
|
8.1
|
|
|
$2.74B
616%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
10K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
8K%
|
-
|
|
NSE: CIPLA
|
$11.12B
3K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
3K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.79B
2K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
2K%
807.02B INR
|
23.1
|
chevron_leftBack